Skip to main content

Table 3 Growth inhibitory effect of Doxorubicin (ID50) with and without CCI-779

From: Overcoming cisplatin resistance by mTOR inhibitor in lung cancer

  DOX (ug/ml) DOX+0.01 ug CCI-779 DOX+1 ug CCI-779
SCLCA 0.09 ± 0.02 0.07 ± 0.01 0.08 ± 0.02
SCLCR 0.042 ± 0.01 0.058 ± 0.02 0.009 ± 0.005